28.62
Galapagos Nv Adr Borsa (GLPG) Ultime notizie
Planisware expands into Belgium to support the sustained growth of its business in the Benelux region - GlobeNewswire Inc.
Galapagos stock holds as CEO change, spinoff plans halted By Investing.com - Investing.com India
Galapagos stock holds as CEO change, spinoff plans halted - Investing.com
Ratios in Focus: Analyzing Galapagos NV ADR (GLPG)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Galapagos stock holds Market Perform rating at Raymond James - Investing.com
Galapagos To Spin Off Innovative Medicines Business - Forbes
Belgium stocks higher at close of trade; BEL 20 up 0.06% - Investing.com
Galapagos stock downgraded to Reduce on strategic concerns - Investing.com
Galapagos stock outlook cautious with clinical readouts on the horizon, says Morgan Stanley - Investing.com
Why This Rival To Gilead, Novartis Just Jumped 10% — And Why There Are Caveats - Investor's Business Daily
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study - Yahoo Finance
Morgan Stanley sets Galapagos stock at equalweight, $38 price target - Investing.com
Billionaire hedge fund manager David Einhorn’s portfolio revealed - Daily Investor
+ND Capital's European Investment Strategy Delivers Again as Sale of CellPoint to Galapagos Paves the Way for Disruptive Point-of-Care Cell Therapy Model for Cancer Patients - Barchart.com
Galapagos Surges On New CEO and Upgrade News - Investing.com
Galapagos NV announces retirement of CEO - Seeking Alpha
Galapagos Gets First Commercial Drug With Jyseleca Approval - Yahoo Finance
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs - Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology - Yahoo Finance
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts - Yahoo Finance
Galapagos NV (GLPG) Stock Price, Trades & News - GuruFocus.com
AIM tech shares that broke America - Interactive Investor
The 5 Best-Performing Non-S&P Stocks of 2015 - Forbes
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):